The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 24 results:
Author Title [ Type(Desc)] Year
Filters: Author is Burroughs, Andrew K  [Clear All Filters]
Journal Article
Cholongitas, E., Vibhakorn S., Lodato F., & Burroughs A. K. (2010).  Angiotensin II antagonists in patients with recurrent hepatitis C virus infection after liver transplantation.. Liver Int. 30(2), 334-5.
Germani, G., Hytiroglou P., Fotiadu A., Burroughs A. K., & Dhillon A. P. (2011).  Assessment of fibrosis and cirrhosis in liver biopsies: an update.. Semin Liver Dis. 31(1), 82-90.
Goulding, C., Cholongitas E., Nair D., Kerry A., Patch D., Akyol M., et al. (2010).  Assessment of reproducibility of creatinine measurement and MELD scoring in four liver transplant units in the UK.. Nephrol Dial Transplant. 25(3), 960-6.
Cholongitas, E., Senzolo M., Patch D., Shaw S., O'Beirne J., & Burroughs A. K. (2009).  Cirrhotics admitted to intensive care unit: the impact of acute renal failure on mortality.. Eur J Gastroenterol Hepatol. 21(7), 744-50.
Vibhakorn, S., Cholongitas E., Kalambokis G., Manousou P., Quaglia A., Marelli L., et al. (2009).  A comparison of four- versus three-pass transjugular biopsy using a 19-G Tru-Cut needle and a randomized study using a cassette to prevent biopsy fragmentation.. Cardiovasc Intervent Radiol. 32(3), 508-13.
Cholongitas, E., Theocharidou E., Vasianopoulou P., Betrosian A., Shaw S., Patch D., et al. (2012).  Comparison of the sequential organ failure assessment score with the King's College Hospital criteria and the model for end-stage liver disease score for the prognosis of acetaminophen-induced acute liver failure.. Liver Transpl. 18(4), 405-12.
Cholongitas, E., Calvaruso V., Betrosian A., Senzolo M., Shaw S., O'Beirne J., et al. (2010).  Critically ill patients with cirrhosis and low serum sodium.. J Clin Gastroenterol. 44(7), 523-4; author reply 524-5.
Papatheodoridis, G. V., Cholongitas E., Archimandritis A. J., & Burroughs A. K. (2009).  Current management of hepatitis B virus infection before and after liver transplantation.. Liver Int. 29(9), 1294-305.
Marelli, L., Xirouchakis E., Kalambokis G., Cholongitas E., Hamilton M. I., & Burroughs A. K. (2011).  Does the severity of primary sclerosing cholangitis influence the clinical course of associated ulcerative colitis?. Gut. 60(9), 1224-8.
Athyros, V. G., Mikhailidis D. P., Didangelos T. P., Giouleme O. I., Liberopoulos E. N., Karagiannis A., et al. (2006).  Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study.. Curr Med Res Opin. 22(5), 873-83.
Senzolo, M., Nadal E., Cholongitas E., & Burroughs A. K. (2011).  Is hydrophobia necessary for the hepatologist prescribing nonselective beta-blockers in cirrhosis?. Hepatology. 53(6), 2149-50.
Cholongitas, E., & Burroughs A. K. (2010).  Is it difficult to obtain an optimal liver biopsy specimen?. Hepatology. 51(1), 355-6.
Cholongitas, E., Papatheodoridis G. V., & Burroughs A. K. (2010).  Liver grafts from anti-hepatitis B core positive donors: a systematic review.. J Hepatol. 52(2), 272-9.
Cholongitas, E., Shusang V., Germani G., Tsochatzis E., Raimondo M. Luisa, Marelli L., et al. (2011).  Long-term follow-up of immunosuppressive monotherapy in liver transplantation: tacrolimus and microemulsified cyclosporin.. Clin Transplant. 25(4), 614-24.
Cholongitas, E., Tsochatzis E., Goulis J., & Burroughs A. K. (2010).  Noninvasive tests for evaluation of fibrosis in HCV recurrence after liver transplantation: a systematic review.. Transpl Int. 23(9), 861-70.
Manousou, P., Samonakis D., Cholongitas E., Patch D., O'Beirne J., Dhillon A. P., et al. (2009).  Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy.. Liver Transpl. 15(12), 1783-91.
Cholongitas, E., Agarwal B., Antoniadis N., & Burroughs A. K. (2012).  Patients with cirrhosis admitted to an intensive care unit.. J Hepatol. 57(1), 230-1; author reply 231-2.
Cholongitas, E., Germani G., & Burroughs A. K. (2010).  Prioritization for liver transplantation.. Nat Rev Gastroenterol Hepatol. 7(12), 659-68.
Cholongitas, E., Manousou P., Samonakis D., & Burroughs A. K. (2009).  Progression of HCV infection in patients with chronic kidney disease.. J Hepatol. 50(3), 621-2; author reply 622.
Cholongitas, E., Calvaruso V., Senzolo M., Patch D., Shaw S., O'Beirne J., et al. (2009).  RIFLE classification as predictive factor of mortality in patients with cirrhosis admitted to intensive care unit.. J Gastroenterol Hepatol. 24(10), 1639-47.
Theocharidou, E., Pieri G., Mohammad A. Omar, Cheung M., Cholongitas E., Agarwal B., et al. (2014).  The Royal Free Hospital score: a calibrated prognostic model for patients with cirrhosis admitted to intensive care unit. Comparison with current models and CLIF-SOFA score.. Am J Gastroenterol. 109(4), 554-62.
Triantos, C. K., Samonakis D., Thalheimer U., Cholongitas E., Senzolo M., Marelli L., et al. (2010).  Terlipressin therapy for renal failure in cirrhosis.. Eur J Gastroenterol Hepatol. 22(4), 481-6.
Cholongitas, E., Germani G., Tsochatzis E., & Burroughs A. K. (2009).  Towards a better liver allocation system.. J Hepatol. 51(4), 827-8.
Marelli, L., Shusang V., Buscombe J. R., Cholongitas E., Stigliano R., Davies N., et al. (2009).  Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.. J Nucl Med. 50(6), 871-7.

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.